http://ift.tt/pnED7n
BOSTON (Reuters) - Insys Therapeutics Inc said on Thursday it was taking a $4.5 million charge in connection with resolving a lawsuit by Illinois' attorney general claiming it deceptively marketed a fentanyl-based cancer pain drug for off-label uses.
Read more
0 comments:
Post a Comment